home / stock / valn / valn articles

VALN Articles, Valneva SE

Stock Information
Company Name: Valneva SE
Stock Symbol: VALN
Market: NASDAQ
Website: valneva.com
Menu
VALN VALN Quote VALN Short VALN News VALN Articles VALN Message Board
Get VALN Alerts

News, Short Squeeze, Breakout and More Instantly...
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June | Benzinga

Saint-Herblain (France), June 4, 2024 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that management will p...
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer | Benzinga

Saint-Herblain (France), May 21, 2024 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced the appointment of Dr....

Valneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 Data | Benzinga

Monday, Valneva SE (NASDAQ:VALN) released further Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine....

National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday. Shares of National CineMedia, Inc. (NASDAQ: NCMI) jumped 25....
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed | Benzinga

Reimbursements deferred by 18 months to start in January 2026 instead of July 2024 Saint-Herblain (France), March 18, 2024 – Valneva SE (NASDA...

Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of Smith & Wesson Brands, Inc. (NASDAQ: SWBI)...

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences | Benzinga

Saint-Herblain (France), March 4, 2024 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that its senior manag...
Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline | Benzinga

Valneva SE (NASDAQ:VALN), on Monday, sold the FDA Priority Review Voucher (PRV) for $103 million (€95 million). The company was awarded...

McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday | Benzinga

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street exp...

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum | Benzinga

Saint-Herblain (France), January 4, 2024 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announces that members of its...
Next 10